Anticoagulant

Type: Keyphrase
Name: Anticoagulant
First reported Apr 15 2014 - Updated 4 hours ago - 1 reports

Tough 2013 for Boehringer but future looks bright

Boehringer Ingelheim has been reflecting on a pretty tough 2013, hurt by manufacturing woes and Pradaxa lawsuits, but its financials were strong and the future looks bright with a raft of product launches coming up.Sales of prescription medicines were ... [Published Pharma Times - Apr 15 2014]
First reported Apr 15 2014 - Updated 19 hours ago - 1 reports

Boehringer Ingelheim revenue slide cushioned by Pradaxa sales jump

German drugmaker reports sales off 4.3% in 2013ShareToolsPradaxa may not be leading the new-age anticoagulant market, but it's certainly leading Boehringer Ingelheim's growth efforts. The blockbuster med made significant gains in 2013 to help offset currency ... [Published FiercePharma - Apr 15 2014]
First reported 19 hours ago - Updated 19 hours ago - 1 reports

Vacuum-Cleaning the Heart

A new minimal invasive bypass system for the drainage of blood has won FDA clearance.Venous thromboembolic disease (VTE) is a dangerous and potentially deadly condition especially for pregnant women and the elderly, annually causing an estimated 150,000 ... [Published European Medical Device Technology - 19 hours ago]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Composition for preserving platelets and method of using the same

The present invention relates to compositions and methods for storing platelets to preserve the function and freshness of the platelets. More particularly, the present invention relates to the use of a preservative composition having an antiplatelet agent, ... [Published Free Patents Online - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 15 2014 - 2 reports

Taking NSAIDs with blood thinners ups bleeding risk

People taking Read: One-quarter of these major bleeds happen within eight days of taking an NSAID, Davidson said. "It's not like you have to be taking them for weeks or months. Some bleeds happen with a single dose," he said.Anticoagulant therapyIt's ... [Published Health24 - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Medication-related emergency department visits and hospitalizations among older adults

AbstractObjective To identify medications that have a high risk of adverse drug effects (ADEs) among seniors, using data from publicly availableadministrative databases.Design Cross-sectional study using the Discharge Abstracts Database (DAD) (which contains ... [Published Canadian Family Physician - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Blood Thinner Blamed For Hundreds Of Injuries, Deaths In Lawsuit

The pharmaceutical company behind the anticoagulant drug Xarelto is facing a lawsuit from a New Jersey woman who claims that her aunt died as a result of using the blood thinner.Della Wise charges that Janssen Research & Development and Bayer Corp. acted ... [Published Medical Daily - Apr 14 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 2 reports

Portola Pharmaceuticals, Inc. Announces Publication Of Phase 3 APEX Study Design And Rationale In

(GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced publication of the design and rationale of the Phase 3 APEX (Acute Medically Ill VTE Prevention with Extended Duration Betrixaban) Study in the March 2014 issue of the American ... [Published BioSpace - Apr 14 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Global anticoagulant drug market to be worth US$5.4Bn in 2017

- 2013 Pharmaceuticals Research Review - a new market research report on companiesandmarkets.comThe global anticoagulant drug market was valued at nearly $5.8 billion in 2011 and reached nearly $5.7 billion in 2012. Total market value is expected to reach ... [Published PR inside - Apr 11 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

New Atrial Fibrillation Guideline Covers Novel Anticoagulants, Ablation

— The 2014 Guideline for the Management of Patients With Atrial Fibrillation includes recommendations for an increased use of radio frequency (RF) ablation in the treatment of non-valvular atrial fibrillation , the addition of three new anticoagulants ... [Published Diagnostic & Invasive Cardiology - Apr 10 2014]
First reported Apr 09 2014 - Updated Apr 10 2014 - 2 reports

FDA approves Pradaxa® for treatment and reduction in the risk of recurrence of deep venous thrombosis and pulmonary embolism

FDA approves Pradaxa® for treatment and reduction in the risk of recurrence of deep venous thrombosis and pulmonary embolismPublic / Patient:0 0 ratingsHealth Professionals:0 0 ratingsRatings require JavaScript to be enabled.Boehringer Ingelheim Pharmaceuticals, ... [Published Medical News Today - Apr 10 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 3 reports

Boehringer Ingelheim receives FDA approval for DVT and PE drug

Boehringer Ingelheim Pharmaceuticals, Inc. has received the FDA approval for Pradaxa indicated for the treatment of deep venous thrombosis, or DVT, and pulmonary embolism, or PE, in patients who have been treated with a parenteral anticoagulant for five ... [Published Individual.com - Apr 09 2014]

Quotes

..."The most important outcome is that patients with significant pharmaceutical care needs are prioritised," says Mrs Caldwell. "In addition, the system makes better use of the pharmacist resource."
...improve patient outcomes and reduce the cost of treatment," said John Soto, Executive Vice President and Chief Commercial Officer of AngioDynamics. "The expanded FDA clearance makes this a more powerful tool for physicians in the U S "
"Studies have shown that hospitals that consistently follow Get With The Guidelines quality improvement measures can reduce patients’ length of stays and 30-day readmission rates and also reduce disparity gaps in care,” Bhatt said. "We are pleased to recognize Atlanta Medical Center for their commitment to heartheart failure care.""
...for innovative medicines is not going to get any easier in the current financial year," board chairman Andreas Barner said in a statement. "In view of this and the impact from the expiry of patents, we expect to achieve net sales for our company in 2014 that are comparable to those in the previous year."

More Content

All (613) | News (506) | Reports (0) | Blogs (102) | Audio/Video (0) | Fact Sheets (0) | Press Releases (5)
sort by: Date | Relevance
Improving patient safety through changing a cli... [Published PJ Online - 46 mins ago]
Vitamin E: a skin-boosting antioxidant that pla... [Published Natural News - 11 hours ago]
Acute Coronary Syndrome Remodels the Protein Ca... [Published PLoS medicine - 19 hours ago]
Vacuum-Cleaning the Heart [Published European Medical Device Technology - 19 hours ago]
Algorithm could be safe for suspected upper-ext... [Published HealthImaging - 23 hours ago]
Atlanta Medical Center Recognized for Outstandi... [Published East Atlanta Patch - 23 hours ago]
Boehringer Ingelheim revenue slide cushioned by... [Published FiercePharma - Apr 15 2014]
Tough 2013 for Boehringer but future looks bright [Published Pharma Times - Apr 15 2014]
New drugs are J&J's Q1 heroes, spurring pharma ... [Published FiercePharma - Apr 15 2014]
Composition for preserving platelets and method... [Published Free Patents Online - Apr 15 2014]
Johnson & Johnson (JNJ) Beats Earnings Estimate... [Published Value Walk - Apr 15 2014]
Taking NSAIDs with blood thinners ups bleeding ... [Published Health24 - Apr 15 2014]
The gatekeepers of gastronomy giving the go-ahe... [Published Guardian.co.uk - Apr 15 2014]
Medication-related emergency department visits ... [Published Canadian Family Physician - Apr 15 2014]
What Are The Health Benefits Of Hing Asafoetida... [Published Pressbox.co.uk - Apr 15 2014]
Cath Lab Safety [Published Cath Lab Digest - Apr 15 2014]
Blood Thinner Blamed For Hundreds Of Injuries, ... [Published Medical Daily - Apr 14 2014]
Blood Thinners, Painkillers Can Be Dangerous Co... [Published NewsMax.com - Apr 14 2014]
Portola Pharmaceuticals, Inc. Announces Publica... [Published BioSpace - Apr 14 2014]
Death Blamed on New Blood Thinner [Published Courthouse News Service - Apr 14 2014]
Portola Pharmaceuticals Announces Publication o... [Published Virtual Strategy Magazine - Apr 14 2014]
Portola Pharma Announces Publication Of Phase 3... [Published RTTNews.com - Apr 14 2014]
Dara BioSciences to Present at the 12th Annual ... [Published BusinessWeek - Apr 14 2014]
Montana mom creates jewelry for parents grievin... [Published Ravalli Republic - Apr 12 2014]
Reishi Mushroom [Published The ASCO Post - Apr 12 2014]
3,000 people in Huddersfield denied heart drug ... [Published Huddersfield Daily Examiner - Apr 11 2014]
Parkridge Medical Center Earns Quality Achievem... [Published Chattanoogan - Apr 11 2014]
Global anticoagulant drug market to be worth US... [Published PR inside - Apr 11 2014]
East Coast Biotech Roundup: Agios, Spero, Cerul... [Published Xconomy - Apr 11 2014]
Regado Biosciences Prices Secondary Offering At... [Published FOXBusiness.com - Apr 11 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
FDA approves Pradaxa® for treatment and reducti... [Published Business Wire Health News - Apr 08 2014]
INGELHEIM, Germany--(BUSINESS WIRE)--For media outside of the U.S., the UK & Canada only Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate) for the treatment of DVT and PE ...
ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 03 2014]
Updated Date: Apr 3, 2014 EST ...
CPDA-1 (Anticoagulant Citrate Phosphate Dextros... [Published DailyMed Drug Label Updates for the last seven ... - Apr 03 2014]
Updated Date: Apr 3, 2014 EST ...
ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 03 2014]
Updated Date: Apr 3, 2014 EST ...
ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 03 2014]
Updated Date: Apr 3, 2014 EST ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Using genomics to make personalized, safer medi... [Published PR Newswire - Feb 03 2014]
Regado Biosciences Announces $20 Million Privat... [Published PR Newswire - Jan 31 2014]
New Safety and Efficacy Data for Pradaxa® (dabi... [Published PR Newswire - Nov 12 2013]
Regado Biosciences, Inc. to Provide Third Quart... [Published PR Newswire - Oct 31 2013]
NATF Launches Atrial Fibrillation Action Initia... [Published PR Newswire - Oct 17 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.